Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| REPLIGEN CORPRGEN · Entity 486 | Chief Financial Officer | May 16, 2023 | May 16, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
REPLIGEN CORP
Report date May 16, 2023 · Filed May 16, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,381 |
Reported balance
After 2023-05-16 transaction · row 1
1 source rowRow 1 · 2023-05-16 · Tax withholding · Disposed 710 · Balance 37,381 F1: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2023 Filed May 16, 2023 23:00 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 710 | $154.03 | $109,361.30 |
DisclosureSEC source: 0000950170-23-022579 · ownership.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,381 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 22:33 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 3,674 | $188.00 | $690,712.00 |
DisclosureSEC source: 0000899243-23-007201 · doc4.xml · nonDerivative · entry 3 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,091 F3 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 22:33 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 8,795 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007201 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,765 F2 · shares: Represents 625 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on January 1, 2022, and 8,170 shares issued pursuant to a PSU award granted to the Issuer on February 27, 2020. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU awards. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 22:33 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 5,019 | $0.00 Strike: $180.48 | $0.00 |
DisclosureSEC source: 0000899243-23-007201 · doc4.xml · derivative · entry 4 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,019 Underlying: Common Stock · 5,019 shares Expires 2033-03-02 F4 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on March 2, 2024, March 2, 2025, and March 2, 2026. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 22:33 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 4,848 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007201 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,970 F1 · shares: Mr. Snodgres was awarded 4,848 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 00:53 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 682 | $173.44 | $118,286.08 |
DisclosureSEC source: 0000899243-23-006511 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,643 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 22:22 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 521 | $173.28 | $90,278.88 |
DisclosureSEC source: 0000899243-23-006613 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,122 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:56 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 5,647 | $200.00 | $1,129,400.00 |
DisclosureSEC source: 0000899243-23-005490 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,325 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 06, 2022. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 21:00 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 466 | $0.00 Strike: $59.52 | $0.00 |
DisclosureSEC source: 0000899243-22-033400 · doc4.xml · derivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,108 Underlying: Common Stock · 466 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 21:00 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 466 | $59.52 | $27,736.32 |
DisclosureSEC source: 0000899243-22-033400 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options was effected pursuant to a 10(b)5-1 trading plan adopted on September 6, 2022. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 20:41 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 970 | $0.00 Strike: $215.58 | $0.00 |
DisclosureSEC source: 0000899243-22-028997 · doc4.xml · derivative · entry 6 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,940 Underlying: Common Stock · 970 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Shares vest and become exercisable as follows: 970 shares on 2/24/2023 and 970 shares on 2/24/2024. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 20:41 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,047 | $0.00 Strike: $86.10 | $0.00 |
DisclosureSEC source: 0000899243-22-028997 · doc4.xml · derivative · entry 5 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,524 Underlying: Common Stock · 3,047 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1,524 shares vest and become exercisable on 2/27/2023. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 20:41 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 2,400 | $253.16 | $607,584.00 |
DisclosureSEC source: 0000899243-22-028997 · doc4.xml · nonDerivative · entry 4 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,506 Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 20:41 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 4,298 | $252.70 | $1,086,104.60 |
DisclosureSEC source: 0000899243-22-028997 · doc4.xml · nonDerivative · entry 3 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,906 F1 · price: $252.70 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.16 to $253.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 20:41 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 970 | $215.58 | $209,112.60 |
DisclosureSEC source: 0000899243-22-028997 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 20:41 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 3,047 | $86.10 | $262,346.70 |
DisclosureSEC source: 0000899243-22-028997 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 21:26 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 2,000 | $220.00 | $440,000.00 |
DisclosureSEC source: 0000899243-22-027415 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,187 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on March 9, 2022. Read SEC document |
| May 13, 2022 Filed May 17, 2022 20:59 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 712 | $150.40 | $107,084.80 |
DisclosureSEC source: 0000899243-22-018416 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,187 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 01:02 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,214 | $0.00 Strike: $59.52 | $0.00 |
DisclosureSEC source: 0000899243-22-010327 · doc4.xml · derivative · entry 4 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,574 Underlying: Common Stock · 1,214 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 01:02 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,952 | $0.00 Strike: $33.87 | $0.00 |
DisclosureSEC source: 0000899243-22-010327 · doc4.xml · derivative · entry 3 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,707 Underlying: Common Stock · 2,952 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 01:02 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 1,214 | $59.52 | $72,257.28 |
DisclosureSEC source: 0000899243-22-010327 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 01:02 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 2,952 | $33.87 | $99,984.24 |
DisclosureSEC source: 0000899243-22-010327 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:52 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 2,468 | $196.70 | $485,455.60 |
DisclosureSEC source: 0000899243-22-008752 · doc4.xml · nonDerivative · entry 4 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,733 F3 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:52 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 5,922 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-008752 · doc4.xml · nonDerivative · entry 3 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,201 F2 · shares: Represents shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on February 28, 2019. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:52 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 661 | $196.70 | $130,018.70 |
DisclosureSEC source: 0000899243-22-008752 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,279 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 00:52 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 695 | $196.70 | $136,706.50 |
DisclosureSEC source: 0000899243-22-008752 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,940 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:10 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 4,410 | $0.00 Strike: $189.21 | $0.00 |
DisclosureSEC source: 0000899243-22-008178 · doc4.xml · derivative · entry 3 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,410 Underlying: Common Stock · 4,410 shares Expires 2032-02-24 F3 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 24, 2023, February 24, 2024 and February 24, 2025. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:10 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 269 | $189.21 | $50,897.49 |
DisclosureSEC source: 0000899243-22-008178 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,635 F2 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:10 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 3,443 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-008178 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,904 F1 · shares: Mr. Snodgres was awarded 3,443 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| February 17, 2022 Filed Feb 23, 2022 00:30 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 332 | $182.42 | $60,563.44 |
DisclosureSEC source: 0000899243-22-007255 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,461 F3 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs. Read SEC document |
| February 17, 2022 Filed Feb 23, 2022 00:30 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-007255 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,793 F1 · shares: Represents shares issued pursuant to Performance Stock Unit ("PSU") award granted to the Issuer on January 4, 2021. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award. F2 · balance_after: The total reported in Column 5 has been adjusted to correct an overstatement of total holdings by 2,000 shares, first reflected in a Form 4 filed on March 2, 2020. Read SEC document |
| May 14, 2021 Filed May 18, 2021 11:49 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 470 | $172.60 | $81,122.00 |
DisclosureSEC source: 0000899243-21-019720 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,893 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F2 · price: $172.60 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.59 to $172.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 04, 2021 Filed Mar 9, 2021 02:50 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 600 | $189.75 | $113,850.00 |
DisclosureSEC source: 0000899243-21-010558 · doc4.xml · nonDerivative · entry 7 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,363 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F8 · price: $189.75 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.14 to $190.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 04, 2021 Filed Mar 9, 2021 02:50 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 603 | $190.45 | $114,841.35 |
DisclosureSEC source: 0000899243-21-010558 · doc4.xml · nonDerivative · entry 6 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,963 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F7 · price: $190.45 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.15 to $190.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 04, 2021 Filed Mar 9, 2021 02:50 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 500 | $191.43 | $95,715.00 |
DisclosureSEC source: 0000899243-21-010558 · doc4.xml · nonDerivative · entry 5 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,566 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F6 · price: $191.43 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.16 to $192.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 04, 2021 Filed Mar 9, 2021 02:50 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 900 | $192.54 | $173,286.00 |
DisclosureSEC source: 0000899243-21-010558 · doc4.xml · nonDerivative · entry 4 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,066 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F5 · price: $192.54 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.22 to $193.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 04, 2021 Filed Mar 9, 2021 02:50 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 242 | $193.72 | $46,880.24 |
DisclosureSEC source: 0000899243-21-010558 · doc4.xml · nonDerivative · entry 3 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,966 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F4 · price: $193.72 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.57 to $194.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 04, 2021 Filed Mar 9, 2021 02:50 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 500 | $196.30 | $98,150.00 |
DisclosureSEC source: 0000899243-21-010558 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,208 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F3 · price: $196.30 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.00 to $196.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 04, 2021 Filed Mar 9, 2021 02:50 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 200 | $197.86 | $39,572.00 |
DisclosureSEC source: 0000899243-21-010558 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,708 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F2 · price: $197.86 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.85 to $197.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 23:11 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 2,910 | $0.00 Strike: $215.58 | $0.00 |
DisclosureSEC source: 0000899243-21-008464 · doc4.xml · derivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,910 Underlying: Common Stock · 2,910 shares Expires 2031-02-24 F2 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 24, 2022, February 24, 2023 and February 24, 2024. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 23:11 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 2,410 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-008464 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,908 F1 · shares: Mr. Snodgres was awarded 2,410 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 02:59 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $33.87 | $0.00 |
DisclosureSEC source: 0000899243-21-003427 · doc4.xml · derivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,887 Underlying: Common Stock · 4,000 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares vest and become exercisable as follows: 6,887 shares on 3/1/2021. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 02:59 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 4,000 | $33.87 | $135,480.00 |
DisclosureSEC source: 0000899243-21-003427 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 59 | $195.77 | $11,550.43 |
DisclosureSEC source: 0000899243-21-000706 · doc4.xml · nonDerivative · entry 7 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,498 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on November 12, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 571 | $195.16 | $111,436.36 |
DisclosureSEC source: 0000899243-21-000706 · doc4.xml · nonDerivative · entry 6 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,557 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on November 12, 2020. F6 · price: $195.16 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.71 to $195.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 218 | $193.88 | $42,265.84 |
DisclosureSEC source: 0000899243-21-000706 · doc4.xml · nonDerivative · entry 5 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,128 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on November 12, 2020. F5 · price: $193.88 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.37 to $193.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 918 | $192.74 | $176,935.32 |
DisclosureSEC source: 0000899243-21-000706 · doc4.xml · nonDerivative · entry 4 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,346 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on November 12, 2020. F4 · price: $192.74 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.37 to $193.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 202 | $190.50 | $38,481.00 |
DisclosureSEC source: 0000899243-21-000706 · doc4.xml · nonDerivative · entry 3 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,264 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on November 12, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 1,333 | $190.09 | $253,389.97 |
DisclosureSEC source: 0000899243-21-000706 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,466 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on November 12, 2020. F3 · price: $190.09 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.45 to $190.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 656 | $188.69 | $123,780.64 |
DisclosureSEC source: 0000899243-21-000706 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,799 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on November 12, 2020. F2 · price: $188.69 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.14 to $189.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.